CORPORATEPROFILE

Otsuka Medical Devices Group Video
www.omd.otsuka.com/en/cv

President’s Message
For patient happiness around the world — oﬀering new and innovative treatment choices
Otsuka Medical Devices was initially established in 2011 with the goal of becoming the third business pillar
supporting the total healthcare mission of the Otsuka group: to contribute to people’s health worldwide.
We are now shifting from the research and development stage to the business phase.
As society ages and lifestyles change, an ever-increasing number of patients suffer from diseases that cannot betreated by pharmaceutical therapies alone. Our focus is on the development of minimally invasive devices asalternative therapeutic choices. In November 2023, our novel therapy, ultrasoundrenal denervation, was approved by the FDA. It is intended as an adjunctive treatment
option for the treatment of hypertension when lifestyle changes and medications
have not adequately controlled a patient’s blood pressure. The therapy is now
commercially available in Europe and the U.S. In Japan, a clinical trial is underway. We
will continue to accelerate our activities to contribute to the health of more patients byoffering alternative treatments like this. Our other key focus areas involve developing
new treatment methods using digital technology, and novel devices incorporating
pharmaceuticals through collaboration with other Otsuka group companies.
We continue to take on the challenges of healthcare with courage and perseverance
to help patients regain their health and live a fulfilling life. As a member of theOtsuka group, a total healthcare company, we strive to contribute to the well-beingof people worldwide.

President and Representative Director
Otsuka Medical Devices Co., Ltd.

Our MissionOtsuka Medical Devices has focused on developing unique solutions that improve the health and well-being ofpatients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve ouraspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology
and drug discovery know-how inherent within the Otsuka group’s heritage.
We will do what it takes to offer patients new innovative treatment choices and stand true to the Otsuka corporate
philosophy : “Otsuka—people creating new products for better health worldwide”.

OtsukaPharmaceutical

OtsukaPharmaceutical
Factory

Taiho
Pharmaceutical

OtsukaWarehouse

OtsukaChemicalOtsukaFoods

Otsuka Group Main Operating Companies

Business Overview
Otsuka Medical Devices is striving to make a difference for patients where existing therapies have either proved
ineffective or the treatment options they need are yet to exist. Through our advanced device technology with
our group members Recor Medical and Veryan Medical, we are confident in our ability to accelerate innovative
treatments such as endovascular therapy to provide solutions to currently untreatable conditions.

Medicine

MedicalDevice

Otsuka Medical Devices
Delivering innovative therapy
for patients

Our Commitment to Quality
The Otsuka group is committed to ensuring the safety of patients and medical professionals through enhancing thequality of its products and continuous improvement of the quality management system. This commitment stretches
back to the group's founding and the words of founder Busaburo Otsuka (1891–1970), “Quality is vital in a factoryand so is packaging. We have to manufacture and market, putting ourselves in the consumer's position.” Otsuka
Medical Devices honored our heritage by establishing an original "quality first" policy that is implemented
throughout our global manufacturing operations to guarantee the delivery of reliable quality worldwide.

Certiﬁed ISO 13485:2016 (September 2022)
Scope of Certification: Design, development, manufacture, distribution,and shipping of vascular stents
Location: Head office, Tokyo Headquarters, HARUMI Technology Center

MD 770118 / ISO 13485

TOPICSHARUMI Technology Center
CROSS DOCK HARUMI 5F 4-7-4, Harumi, Chuo-ku, Tokyo
Established in July 2021, HARUMI Technology Center houses state-of-the-art
laboratory facilities, cleanrooms, and a Learning Studio that showcases
features and clinical applications of our products. The center doubles as a
global research hub that connects us with our partners and medical
professionals in Japan and overseas.

Otsuka Medical Devices’ Global Network
Otsuka Medical Devices works in tandem with affiliated companies worldwide via a global R&D network. Throughknowledge sharing and the integration of technology, the network is an international platform for providing
innovative treatments for patients.

Veryan Medical Limited

Recor Medeical, Inc.

Horsham, West Sussex, UK

Palo Alto, California, USAJIMRO Co., Ltd.

Corporate Overview
Company Name

Otsuka Medical Devices Co., Ltd.

EstablishedFebruary 15th, 2011

Capital7.55 billion yen

Address

2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048, Japan

Main Oﬃce

Shinagawa Grand Central Tower 13F
2-16-4, Konan, Minato-ku, Tokyo 108-0075, Japan

TEL, FAX

TEL +81-3-6361-7459 FAX +81-3-3471-1477

Number of Employees

134 (As of June 30, 2024)
640 across Otsuka Medical Devices Group (As of December 31, 2023)

Business Description

R&D, manufacture, and sales of medical devices and all related operations, as well as
medical device operational management for companies within the Otsuka group

Shareholder

Otsuka Holdings Co., Ltd. (100%)

Group Members[ Japan] JIMRO Co., Ltd.
[USA] Recor Medical, Inc. [UK] Veryan Medical Limited[DE] Otsuka Medical Devices Europe GmbHwww.omd.otsuka.com/en/
No part of this document may be reproduced or duplicated in any form orby any means without the prior written permission of Otsuka Medical Devices Co., Ltd.